Cargando…
Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854117/ https://www.ncbi.nlm.nih.gov/pubmed/36686801 http://dx.doi.org/10.3389/fonc.2022.1124912 |
| _version_ | 1784873047293952000 |
|---|---|
| author | Prasopporn, Sunisa Suppramote, Orawan Ponvilawan, Ben Jamyuang, Chanette Chanthercrob, Jantappapa Chaiboonchoe, Amphun More-Krong, Pimkanya Kongsri, Kamonchanok Suntiparpluacha, Monthira Chanwat, Rawisak Korphaisarn, Krittiya Okada, Seiji Sampattavanich, Somponnat Jirawatnotai, Siwanon |
| author_facet | Prasopporn, Sunisa Suppramote, Orawan Ponvilawan, Ben Jamyuang, Chanette Chanthercrob, Jantappapa Chaiboonchoe, Amphun More-Krong, Pimkanya Kongsri, Kamonchanok Suntiparpluacha, Monthira Chanwat, Rawisak Korphaisarn, Krittiya Okada, Seiji Sampattavanich, Somponnat Jirawatnotai, Siwanon |
| author_sort | Prasopporn, Sunisa |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9854117 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98541172023-01-21 Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma Prasopporn, Sunisa Suppramote, Orawan Ponvilawan, Ben Jamyuang, Chanette Chanthercrob, Jantappapa Chaiboonchoe, Amphun More-Krong, Pimkanya Kongsri, Kamonchanok Suntiparpluacha, Monthira Chanwat, Rawisak Korphaisarn, Krittiya Okada, Seiji Sampattavanich, Somponnat Jirawatnotai, Siwanon Front Oncol Oncology Frontiers Media S.A. 2023-01-06 /pmc/articles/PMC9854117/ /pubmed/36686801 http://dx.doi.org/10.3389/fonc.2022.1124912 Text en Copyright © 2023 Prasopporn, Suppramote, Ponvilawan, Jamyuang, Chanthercrob, Chaiboonchoe, More-Krong, Kongsri, Suntiparpluacha, Chanwat, Korphaisarn, Okada, Sampattavanich and Jirawatnotai https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Prasopporn, Sunisa Suppramote, Orawan Ponvilawan, Ben Jamyuang, Chanette Chanthercrob, Jantappapa Chaiboonchoe, Amphun More-Krong, Pimkanya Kongsri, Kamonchanok Suntiparpluacha, Monthira Chanwat, Rawisak Korphaisarn, Krittiya Okada, Seiji Sampattavanich, Somponnat Jirawatnotai, Siwanon Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma |
| title | Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma |
| title_full | Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma |
| title_fullStr | Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma |
| title_full_unstemmed | Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma |
| title_short | Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma |
| title_sort | corrigendum: combining the smac mimetic lcl161 with gemcitabine plus cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854117/ https://www.ncbi.nlm.nih.gov/pubmed/36686801 http://dx.doi.org/10.3389/fonc.2022.1124912 |
| work_keys_str_mv | AT prasoppornsunisa corrigendumcombiningthesmacmimeticlcl161withgemcitabinepluscisplatintherapyinhibitsandpreventstheemergenceofmultidrugresistanceincholangiocarcinoma AT suppramoteorawan corrigendumcombiningthesmacmimeticlcl161withgemcitabinepluscisplatintherapyinhibitsandpreventstheemergenceofmultidrugresistanceincholangiocarcinoma AT ponvilawanben corrigendumcombiningthesmacmimeticlcl161withgemcitabinepluscisplatintherapyinhibitsandpreventstheemergenceofmultidrugresistanceincholangiocarcinoma AT jamyuangchanette corrigendumcombiningthesmacmimeticlcl161withgemcitabinepluscisplatintherapyinhibitsandpreventstheemergenceofmultidrugresistanceincholangiocarcinoma AT chanthercrobjantappapa corrigendumcombiningthesmacmimeticlcl161withgemcitabinepluscisplatintherapyinhibitsandpreventstheemergenceofmultidrugresistanceincholangiocarcinoma AT chaiboonchoeamphun corrigendumcombiningthesmacmimeticlcl161withgemcitabinepluscisplatintherapyinhibitsandpreventstheemergenceofmultidrugresistanceincholangiocarcinoma AT morekrongpimkanya corrigendumcombiningthesmacmimeticlcl161withgemcitabinepluscisplatintherapyinhibitsandpreventstheemergenceofmultidrugresistanceincholangiocarcinoma AT kongsrikamonchanok corrigendumcombiningthesmacmimeticlcl161withgemcitabinepluscisplatintherapyinhibitsandpreventstheemergenceofmultidrugresistanceincholangiocarcinoma AT suntiparpluachamonthira corrigendumcombiningthesmacmimeticlcl161withgemcitabinepluscisplatintherapyinhibitsandpreventstheemergenceofmultidrugresistanceincholangiocarcinoma AT chanwatrawisak corrigendumcombiningthesmacmimeticlcl161withgemcitabinepluscisplatintherapyinhibitsandpreventstheemergenceofmultidrugresistanceincholangiocarcinoma AT korphaisarnkrittiya corrigendumcombiningthesmacmimeticlcl161withgemcitabinepluscisplatintherapyinhibitsandpreventstheemergenceofmultidrugresistanceincholangiocarcinoma AT okadaseiji corrigendumcombiningthesmacmimeticlcl161withgemcitabinepluscisplatintherapyinhibitsandpreventstheemergenceofmultidrugresistanceincholangiocarcinoma AT sampattavanichsomponnat corrigendumcombiningthesmacmimeticlcl161withgemcitabinepluscisplatintherapyinhibitsandpreventstheemergenceofmultidrugresistanceincholangiocarcinoma AT jirawatnotaisiwanon corrigendumcombiningthesmacmimeticlcl161withgemcitabinepluscisplatintherapyinhibitsandpreventstheemergenceofmultidrugresistanceincholangiocarcinoma |